Mechanisms of angiogenesis and arteriogenesis
暂无分享,去创建一个
[1] N. Glazer,et al. Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.
[2] J. Alroy,et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy , 2000, Nature Medicine.
[3] M. Fishman,et al. gridlock, an HLH gene required for assembly of the aorta in zebrafish. , 2000, Science.
[4] S. Rafii,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.
[5] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[6] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[7] T. Yagi,et al. A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.
[8] P. Carmeliet. Developmental biology: Controlling the cellular brakes , 1999, Nature.
[9] W. Gerald,et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.
[10] A. Luttun,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.
[11] C. Compton,et al. Tumor–host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1 , 1999, Nature Medicine.
[12] G. Yancopoulos,et al. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.
[13] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[14] Erkki Ruoslahti,et al. Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.
[15] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[16] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[17] J. Peng,et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. , 1999, Development.
[18] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[19] B. Brooke,et al. Defective angiogenesis in mice lacking endoglin. , 1999, Science.
[20] G. Yancopoulos,et al. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.
[21] Willem Flameng,et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.
[22] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[23] M Aguet,et al. VEGF is required for growth and survival in neonatal mice. , 1999, Development.
[24] G. Lyons,et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. , 1998, Development.
[25] R. Hynes,et al. Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.
[26] K. Alitalo,et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. , 1998, Science.
[27] Thomas N. Sato,et al. Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.
[28] C. Betsholtz,et al. Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. , 1998, Current opinion in lipidology.
[29] D. McDonald,et al. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. , 1998, The American journal of pathology.
[30] G. Semenza. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. , 1998, Current opinion in genetics & development.
[31] R K Jain,et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] W. Risau,et al. Development and differentiation of endothelium. , 1998, Kidney international. Supplement.
[33] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Skobe,et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.
[35] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[36] S. Patan,et al. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. , 1998, Microvascular research.
[37] R. Hammer,et al. Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. , 1998, The Journal of clinical investigation.
[38] T. Mikawa,et al. Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] Dean Y. Li,et al. Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.
[40] S. Narumiya,et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. , 1998, Biochemical and biophysical research communications.
[41] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[42] E. Keshet,et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.
[43] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[44] P. Huang,et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.
[45] D. Cheresh,et al. Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.
[46] S. Pawlowski,et al. Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.
[47] W. Denetclaw,et al. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. , 1998, Developmental biology.
[48] A. G. Gittenberger-de Groot,et al. Differences in development of coronary arteries and veins. , 1997, Cardiovascular research.
[49] H. Dietz,et al. Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.
[50] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[51] Janet Rossant,et al. A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.
[52] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[53] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[54] David Baunoch,et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT , 1997, Nature.
[55] Rakesh K. Jain,et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.
[56] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[57] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[58] W. Schaper,et al. Molecular mechanisms of coronary collateral vessel growth. , 1996, Circulation research.
[59] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[60] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[61] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[62] D. Cheresh,et al. Review: The Integrin αvβ3: Angiogenesis and Apoptosis , 1995 .
[63] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[64] A. Kulkarni,et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.
[65] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[66] Cord Sunderkötter,et al. Macrophages and angiogenesis , 1994, Journal of leukocyte biology.
[67] P. Carmeliet,et al. PR39, a peptide regulator of angiogenesis , 2000, Nature Medicine.
[68] N. Ferrara,et al. Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis , 1999 .
[69] M. Karkkainen,et al. Vascular endothelial growth factor receptor-3. , 1999, Current topics in microbiology and immunology.
[70] L. Leatherbury,et al. Role of cardiac neural crest cells in cardiovascular development. , 1998, Annual review of physiology.
[71] R. A. Gomez,et al. Renin-expressing cells are associated with branching of the developing kidney vasculature. , 1998, Journal of the American Society of Nephrology : JASN.